REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,769,000 | -72.9% | 67,071 | +3.4% | 0.00% | -75.0% |
Q3 2021 | $6,525,000 | -28.9% | 64,858 | +0.0% | 0.00% | -33.3% |
Q2 2021 | $9,177,000 | +173.5% | 64,838 | +92.7% | 0.01% | +200.0% |
Q1 2021 | $3,355,000 | -21.0% | 33,653 | -2.1% | 0.00% | -33.3% |
Q4 2020 | $4,248,000 | +27.1% | 34,365 | +0.1% | 0.00% | 0.0% |
Q3 2020 | $3,343,000 | -37.1% | 34,316 | +0.7% | 0.00% | -40.0% |
Q2 2020 | $5,318,000 | +44.3% | 34,085 | +33.5% | 0.01% | +25.0% |
Q1 2020 | $3,685,000 | -42.0% | 25,527 | -17.9% | 0.00% | -33.3% |
Q4 2019 | $6,356,000 | +169.2% | 31,091 | +5.7% | 0.01% | +200.0% |
Q3 2019 | $2,361,000 | -21.6% | 29,403 | -7.9% | 0.00% | -33.3% |
Q2 2019 | $3,011,000 | +10.1% | 31,909 | -0.3% | 0.00% | 0.0% |
Q1 2019 | $2,735,000 | +18.6% | 31,996 | -22.2% | 0.00% | 0.0% |
Q4 2018 | $2,307,000 | -6.3% | 41,124 | +36.5% | 0.00% | +50.0% |
Q3 2018 | $2,463,000 | – | 30,124 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |